Invited Speaker Asia-Pacific Vaccine and Immunotherapy Congress 2024

The JAK inhibitor baricitinib preserves beta-cell function in patients with new-onset type 1 diabetes (#12)

Helen Thomas 1
  1. St Vincent's Institute, Fitzroy, VIC, Australia

Abstract coming soon!